- High Dose Rate Brachytherapy
- Low Dose Rate Brachytherapy
Brachytherapy Devices Market size is valued at USD 792.2 million in 2022 and is poised to grow at a CAGR of 7.4% from 2023 to 2029. The global market provides a detailed overview of the market and can be segmented by type, application, end-user, and region. By type, the Brachytherapy Devices market has been segmented into high-dose rate brachytherapy and low-dose-rate brachytherapy. By type, the high dose rate brachytherapy segment dominated the market and accounted for the largest revenue share in past years. The high-dose rate therapy is generally done as an outpatient procedure for the treatment of various types of cancers such as skin, cervical, prostate, head, neck, and breast cancer within a short procedure time, with higher efficacy, and protection from radiation exposure. By application, the Brachytherapy Devices market has been segmented into gynecological cancer, prostate cancer, skin cancer, breast cancer, cervical cancer, and others. By application, the breast cancer segment is expected to witness the highest CAGR during the forecast period owing to the increasing usage of brachytherapy in accelerated partial breast irradiation (APBI). Furthermore, the rising incidence of breast cancer is also expected to propel the growth of this segment. Based on the end user, the segment has been segregated into hospitals, diagnostic centers, ambulatory surgical centers, and radiotherapy centers. The radiotherapy centers segment is expected to lead the end-user segments owing to continuous development in cancer treatment devices by numerous radiotherapy centers across developed countries.
Brachytherapy Devices Market Key Development:
Study Period
Base Year
CAGR
Largest Market
Fastest Growing Market
The rising prevalence of cancer, technological advancements, and a substantial rise in the adoption of brachytherapy are expected to drive the growth of the market during the forecast period.
The brachytherapy devices market size was valued at USD 792.2 million in 2022.
The brachytherapy devices market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.
The brachytherapy devices market key players Varian Medical Systems, Inc. (U.S.) Ion Beam Applications (IBA) (Belgium) Accuray Incorporated (U.S.) Nordion, Inc. (Canada) Elekta AB (Sweden) Isoray Medical, Inc. (U.S.) R. Bard, Inc. (U.S.) ViewRay, Inc. (U.S.) RaySearch Laboratories (Sweden) Mitsubishi Electric Corporation (Japan) Mevion Medical Systems, Inc. (U.S.)
1.Executive Summary |
2.Global Brachytherapy Devices Market Introduction |
2.1.Global Brachytherapy Devices Market - Taxonomy |
2.2.Global Brachytherapy Devices Market - Definitions |
2.2.1.Type |
2.2.2.Application |
2.2.3.End User |
2.2.4.Region |
3.Global Brachytherapy Devices Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Product Landscape |
3.6. New Product Launches |
3.7. Impact of COVID 19 on Market |
4.Global Brachytherapy Devices Market Analysis, 2018 - 2022 and Forecast 2023 - 2029 |
4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5.Global Brachytherapy Devices Market By Type, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
5.1. High Dose Rate Brachytherapy |
5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Low Dose Rate Brachytherapy |
5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
6.Global Brachytherapy Devices Market By Application, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
6.1. Gynaecological cancer |
6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Prostate cancer |
6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Skin Cancer |
6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
6.4. Breast cancer |
6.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.4.3. Market Opportunity Analysis |
6.5. Cervical Cancer |
6.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.5.3. Market Opportunity Analysis |
6.6. Others |
6.6.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
6.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.6.3. Market Opportunity Analysis |
7.Global Brachytherapy Devices Market By End User, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
7.1. Hospitals |
7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Diagnostic Centres |
7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Ambulatory surgical centres |
7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
7.4. Radiotherapy Centres |
7.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.4.3. Market Opportunity Analysis |
8.Global Brachytherapy Devices Market By Region, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
8.1. North America |
8.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Europe |
8.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
8.3. Asia Pacific (APAC) |
8.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.3.3. Market Opportunity Analysis |
8.4. Middle East and Africa (MEA) |
8.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.4.3. Market Opportunity Analysis |
8.5. Latin America |
8.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.5.3. Market Opportunity Analysis |
9.North America Brachytherapy Devices Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
9.1. Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.1.1.High Dose Rate Brachytherapy |
9.1.2.Low Dose Rate Brachytherapy |
9.2. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.2.1.Gynaecological cancer |
9.2.2.Prostate cancer |
9.2.3.Skin Cancer |
9.2.4.Breast cancer |
9.2.5.Cervical Cancer |
9.2.6.Others |
9.3. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.3.1.Hospitals |
9.3.2.Diagnostic Centres |
9.3.3.Ambulatory surgical centres |
9.3.4.Radiotherapy Centres |
9.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.4.1.United States of America (USA) |
9.4.2.Canada |
10.Europe Brachytherapy Devices Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
10.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.1.1.High Dose Rate Brachytherapy |
10.1.2.Low Dose Rate Brachytherapy |
10.2. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.2.1.Gynaecological cancer |
10.2.2.Prostate cancer |
10.2.3.Skin Cancer |
10.2.4.Breast cancer |
10.2.5.Cervical Cancer |
10.2.6.Others |
10.3. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.3.1.Hospitals |
10.3.2.Diagnostic Centres |
10.3.3.Ambulatory surgical centres |
10.3.4.Radiotherapy Centres |
10.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.4.1.Germany |
10.4.2.France |
10.4.3.Italy |
10.4.4.United Kingdom (UK) |
10.4.5.Spain |
10.4.6.Rest of EU |
11.Asia Pacific (APAC) Brachytherapy Devices Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
11.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.1.1.High Dose Rate Brachytherapy |
11.1.2.Low Dose Rate Brachytherapy |
11.2. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.2.1.Gynaecological cancer |
11.2.2.Prostate cancer |
11.2.3.Skin Cancer |
11.2.4.Breast cancer |
11.2.5.Cervical Cancer |
11.2.6.Others |
11.3. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.3.1.Hospitals |
11.3.2.Diagnostic Centres |
11.3.3.Ambulatory surgical centres |
11.3.4.Radiotherapy Centres |
11.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.4.1.China |
11.4.2.India |
11.4.3.Australia and New Zealand (ANZ) |
11.4.4.Japan |
11.4.5.Rest of APAC |
12.Middle East and Africa (MEA) Brachytherapy Devices Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
12.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.1.1.High Dose Rate Brachytherapy |
12.1.2.Low Dose Rate Brachytherapy |
12.2. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.2.1.Gynaecological cancer |
12.2.2.Prostate cancer |
12.2.3.Skin Cancer |
12.2.4.Breast cancer |
12.2.5.Cervical Cancer |
12.2.6.Others |
12.3. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.3.1.Hospitals |
12.3.2.Diagnostic Centres |
12.3.3.Ambulatory surgical centres |
12.3.4.Radiotherapy Centres |
12.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.4.1.GCC Countries |
12.4.2.South Africa |
12.4.3.Rest of MEA |
13.Latin America Brachytherapy Devices Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
13.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.1.1.High Dose Rate Brachytherapy |
13.1.2.Low Dose Rate Brachytherapy |
13.2. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.2.1.Gynaecological cancer |
13.2.2.Prostate cancer |
13.2.3.Skin Cancer |
13.2.4.Breast cancer |
13.2.5.Cervical Cancer |
13.2.6.Others |
13.3. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.3.1.Hospitals |
13.3.2.Diagnostic Centres |
13.3.3.Ambulatory surgical centres |
13.3.4.Radiotherapy Centres |
13.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.4.1.Brazil |
13.4.2.Mexico |
13.4.3.Rest of LA |
14. Competition Landscape |
14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
14.2.1.Varian Medical Systems, Inc. (U.S.) |
14.2.2.Ion Beam Applications (IBA) (Belgium) |
14.2.3.Accuray Incorporated (U.S.) |
14.2.4.Nordion, Inc. (Canada) |
14.2.5.Elekta AB (Sweden) |
14.2.6.Isoray Medical, Inc. (U.S.) |
14.2.7.R. Bard, Inc. (U.S.) |
14.2.8.ViewRay, Inc. (U.S.) |
14.2.9.RaySearch Laboratories (Sweden) |
14.2.10.Mitsubishi Electric Corporation (Japan) |
14.2.11.Mevion Medical Systems, Inc. (U.S.) |
15. Research Methodology |
16. Appendix and Abbreviations |